Septic Shock
Conditions
Keywords
Deresuscitation, Central Venous Pressure, Septic Shock, Furosemide
Brief summary
A scientific research to prove the safety and effectiveness of TVS 0 - 4 mmHg as a target of resuscitation using furosemide, to improve Perfused Vessel Density (PVD) \> 25 mm / mm2, AKI stage (based on KDIGO criteria), CI \> 2.5 cc / min / m2 , prevent the incidence of intubation, reduce the duration of ventilator use \<120 hours and reduce the length of ICU stay in patients with septic shock after resuscitation
Detailed description
The study aims to evaluate the effectiveness of deresuscitation with target CVP 0 - 4 mmHg on septic shock patients in the ICU on capillary perfusion density, AKI stage (based on KDIGO criteria), the incidence of intubation, duration of use of mechanical ventilation, and length of stay in the ICU which can reduce the number of morbidity and mortality. The study evaluates the difference in capillary perfusion density, AKI stage (based on KDIGO criteria), and the Cardiac index value between groups septic shock patients with CVP 0-4 mmHg on the 7th day after deresuscitation compared with the control group (CVP 8-10 mmHg on the first 7th day after being given deresuscitation). The study evaluates the difference in the number of intubation incidents, duration of use ventilators, and care in the ICU between groups of patients with septic shock CVP 0 - 4 on day 28 after being given a degree of comparison with a control group (CVP 8-10 mmHg on day 28th after being deresuscitation).
Interventions
Crystalloid loading or furosemide administration with the CVP target 8-10 mmHg is reached in septic shock patients
active fluid removal with furosemide bolus and continuous or crystalloid loading until the CVP target 0-4 mmHg is reached in septic shock patients
Sponsors
Study design
Eligibility
Inclusion criteria
* Septic shock patients who meet the diagnosis criteria for quick SOFA and KDIGO 1 stage AKI (creatinine value 1.5 times OR creatinine value\> 0.3 initial OR urine production \<0.5 ml/kg/hour for 6-12 hours * Patients, both men and women, in the age range of 18 - 60 years * Patients who experience post clean operative sepsis * Patients who agree to attend the study by signing informed consent
Exclusion criteria
* Patients with primary heart problems, right or heart failure suffer from congenital heart disease * Have severe chronic obstructive pulmonary disease, patients with severe pleural effusion * Patients who, based on ultrasound examination, found stones or tumors in the kidney during the study period * CKD patients are based on history taking and physical examination * DNR (do not resuscitate) patients
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Capillary Perfusion Density | 7 days | Capillary Perfusion Density measurement using MicroScan every 24 hours during deresuscitation |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Acute Kidney Injury Stage | 7 days | AKI staging using KDIGO criteria every 24 hours during deresuscitation |
| Cardiac Index | 7 days | cardiac index measurement using bio-impedance cardiometry every 24 hours during deresuscitation |
| Neutrophil Gelatinase-Associated lipocalin (NGAL) | 1st and 7th day | NGAL measurement from urinary sample using NGAL ELISA method at 1st and 7th day during deresuscitation |
| Renal Resistive Index (RRI) | 1st and 7th day | RRI measurement using renal doppler ultrasonography at 1st and 7th day during deresuscitation |
| Length of ICU stay | 28 days | length of ICU stay in days during and after deresuscitation |
Countries
Indonesia